Cargando…
On the Treatment of Pneumocystis jirovecii Pneumonia: Current Practice Based on Outdated Evidence
Pneumocystis jirovecii pneumonia (PCP) is a common opportunistic infection causing more than 400000 cases annually worldwide. Although antiretroviral therapy has reduced the burden of PCP in persons with human immunodeficiency virus (HIV), an increasing proportion of cases occur in other immunocompr...
Autores principales: | McDonald, Emily G, Butler-Laporte, Guillaume, Del Corpo, Olivier, Hsu, Jimmy M, Lawandi, Alexander, Senecal, Julien, Sohani, Zahra N, Cheng, Matthew P, Lee, Todd C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694206/ https://www.ncbi.nlm.nih.gov/pubmed/34988242 http://dx.doi.org/10.1093/ofid/ofab545 |
Ejemplares similares
-
Low-Dose TMP-SMX in the Treatment of Pneumocystis jirovecii Pneumonia: A Systematic Review and Meta-analysis
por: Butler-Laporte, Guillaume, et al.
Publicado: (2020) -
Remdesivir for the treatment of COVID-19: a systematic review and meta-analysis
por: Lee, Todd C., et al.
Publicado: (2022) -
Radiographic features in investigated for Pneumocystis jirovecii pneumonia: a nested case-control study
por: Hsu, Jimmy M., et al.
Publicado: (2020) -
Low-dose trimethoprim-sulfamethoxazole for the treatment of Pneumocystis jirovecii pneumonia (LOW-TMP): protocol for a phase III randomised, placebo-controlled, dose-comparison trial
por: Sohani, Zahra N., et al.
Publicado: (2022) -
Pneumocystis jirovecii pneumonia in developing countries
por: De Armas Rodríguez, Y., et al.
Publicado: (2011)